Qualcomm wins Arm licensing lawsuit, Arm seeks retrial



In 2022, Arm, a major semiconductor design company, filed a lawsuit against fellow semiconductor manufacturer Qualcomm, claiming that Qualcomm designs products using technology from Nuvia, which it

acquired in 2021, and that the designs developed under the license agreement between Nuvia and Arm should be discarded. Regarding this lawsuit, a federal court in Delaware ruled on December 21, 2024 that Qualcomm had not violated the terms of the contract and dismissed Arm's claims.

Qualcomm (QCOM) Wins Licensing Fight With Arm Over Chip Designs - Bloomberg
https://www.bloomberg.com/news/articles/2024-12-20/qualcomm-wins-licensing-fight-with-arm-over-chip-designs



Qualcomm secures key win in chips trial against Arm | Reuters
https://www.reuters.com/legal/us-jury-deadlocked-arm-trial-against-qualcomm-still-deliberating-2024-12-20/

Arm will seek a new trial against Qualcomm | Tom's Hardware
https://www.tomshardware.com/tech-industry/arm-plans-to-retrial-its-litigation-with-qualcomm

The lawsuit stems from Qualcomm's acquisition of Nuvia, a startup that develops its own Arm cores, in 2021. Qualcomm has since used the Arm cores developed by Nuvia in its Windows PC SoCs, the Snapdragon X Elite and Snapdragon X Plus .

However, Arm claims that the license it granted to Nuvia was for its own Arm cores and did not permit them to be used in other companies' products. In addition, Arm filed a lawsuit in August 2022, demanding that Qualcomm cease and desist from using and destroy the technology and products developed under the license agreement between Nuvia and Arm, as it had not received consent to transfer Nuvia's license to Qualcomm.

Qualcomm, who was asked by Arm to 'destroy products that violate the license,' countersued, saying 'Arm's argument is unjust' - GIGAZINE



On December 21, 2024, the Delaware federal court concluded that Qualcomm had not violated the license agreement between Nuvia and Arm. It also determined that Qualcomm's Snapdragon X Elite and Snapdragon X Plus were properly licensed under its own agreement with Arm, allowing Qualcomm to continue selling these products. In response, Qualcomm said that the jury upheld Qualcomm's right to innovation and recognized that all Qualcomm products at issue in this lawsuit are protected by license.

However, not all of Qualcomm's rights were recognized in this trial, and the jury was unable to reach a consensus on the issue of whether Nuvia had transferred licenses to Qualcomm in violation of its license with Arm. Judge Mariel Noreika reported that 'this issue alone may be retried at a later date.'

Following the outcome of the trial, analyst Daniel Newman quoted Arm as saying, 'We are disappointed that the jury was unable to reach an agreement on the full extent of the allegations. We intend to seek a retrial on the issues on which we disagree,' suggesting that further trials may follow.




Related Posts:

in Note, Posted by log1r_ut